The Trump administration has finalized a deal with drugmaker AbbVie to cut the cost of certain medicines, marking the latest pact as part of its “Most Favored Nation” pricing initiative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback